The Value of Targeting CXCR4 with 68Ga-Pentixafor PET/CT for Subtyping Primary Aldosteronism. Zheng Y, Long T, Peng N, Zhen M, et al. J Clin Endocrinol Metab 2023 Jul 21:dgad421. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zheng Y, Long T, Peng N, Zhen M, et al. The Value of Targeting CXCR4 with 68Ga-Pentixafor PET/CT for Subtyping Primary Aldosteronism. J Clin Endocrinol Metab 2023 Jul 21:dgad421. doi: 10.1210.
PMID: 37477496